ERBB2 and cancer: We co-cultured the iPS-ML/anti-HER2 expressing additional anti-cancer molecules with luciferase-expressing NUGC-4 cells and analyzed the number of live NUGC-4 cells based on luciferase activity after 3 days (Fig. 4).